FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hetero Labs Limited Unit V Montelukast Sodium Tablets Recall

Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs…

Hetero Labs Limited Unit V

Risk level
Class II
Reported by FDA
Oct 3, 2018
Recall ID
D-1213-2018
Check your lot numberHow we source this data

Summary

Hetero Labs Limited Unit V recalled Montelukast Sodium Tablets starting Aug 20, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1213-2018 on Oct 3, 2018. Reason: Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets. Status: Terminated.

Why it was recalled

Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.

Product description

Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.

Lot numbers, UPCs & expiration codes

Lot #: MON17355, Exp 12/19

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1213-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 20, 2018
FDA report date
Oct 3, 2018
Quantity
98,016 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs Limited Unit V

Original FDA data

Every field from FDA enforcement report D-1213-2018, exactly as published.

Show all FDA fields
City
Jadcherla Mandal, Mahaboob Nagar
Status
Terminated
Country
India
Event ID
81029
Address
Unit V (SEZ Unit I in APIIC SEZ)
Address (line 2)
Surv. No. 439-441, 458, Polepally Vill.
Code information
Lot #: MON17355, Exp 12/19
Report date
Oct 3, 2018
Product type
Drugs
Recall number
D-1213-2018
Classification
Class II
Recalling firm
Hetero Labs Limited Unit V
Product quantity
98,016 bottles
Termination date
Nov 5, 2021
Reason for recall
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 20, 2018
Initial firm notification
Letter
Center classification date
Sep 26, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1213-2018, published Oct 3, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls